Skip to content

Efficacy of Anti-dry cream in treatment of hand eczema

Evaluating of Anti-dry cream vs Flucinolone acetonide 0/o25% cream in treatment of hand eczema

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201212303734N2
Enrollment
108
Registered
2013-08-30
Start date
2011-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand eczema. ICD-10: Dermatitis unspecified Eczema NOS

Interventions

Intervention 1: Intervention group: Anti dry® cream (contains Aleo vera essence, Geranium essence, Lavander essence, respectively, with ratio of 50:1:15 in vanishing cream), 1FTU (finger tip unit= 0.
Treatment - Drugs
Intervention group: Anti dry® cream (contains Aleo vera essence, Geranium essence, Lavander essence, respectively, with ratio of 50:1:15 in vanishing cream), 1FTU (finger tip unit= 0.5g) for 10×10 cm
control group: fluocinolon acetonide cream 0.025%, twice daily, for two weeks

Sponsors

Barij Essence Herbal Medicine Research Center
Lead Sponsor
Vice chancellor for research, Kashan University of Medical Sciences
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Main inclusion criteria: age between 18-75y/o; patients should be eager to participate in trial; patients with hand eczema that is confirmed by dermatologist. Main exclusion criteria: pregnancy and lactation; application of topical drugs during previous two weeks; systemic therapies such as corticosteroids, immunosupressive drugs and antibiotics during the past 4 weeks; localized hand infection; history of allergic reaction to the study medications.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Change of signs and symptoms of hand eczema. Timepoint: The days of 0 and 14. Method of measurement: Questionnaire (contains of clinical signs and symptoms: erythema, scaling, lichenification/ hyperkeratosis, edema,vesicle, fissure, pruritus and pain).

Secondary

MeasureTime frame
Side effects of drugs. Timepoint: 14 days after prescription of drug. Method of measurement: Change of pruritus, erythema and scaling, bullae.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRezvan Talaee

Kashan university of medical sciences

R_talaee2007@yahoo.com+98 361555002126

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026